NASDAQ, XOMA - Xoma Royalty Corporation
XOMA Ltd. (?XOMA? or the ?Company?), a Bermuda company, is a leading
biopharmaceutical company focused on the discovery, development and manufacture
of therapeutic antibodies. XOMA uses its expertise, technologies and
capabilities to build a product pipeline that includes multiple proprietary and
collaborative development programs. The Company?s lead product candidate is XOMA
052, a high affinity anti-IL-1 beta antibody with the potential to treat
multiple inflammatory diseases of large unmet need. XOMA 052 is currently in
Phase 1 clinical studies of Type 2 diabetes patients.
XOMA has multiple revenue streams and generates revenues from product royalties,
technology licenses, development collaborations and biodefense contracts. ...
Read SEC Filing on NASDAQ.com »